TARGETING THE POLYCOMB REPRESSIVE COMPLEX 2 IN NEUROFIBROMATOSIS TYPE 2 AND SCHWANNOMATOSIS

$683,819FY2025Defense Health AgencyDOD

Mayo Clinic Jacksonville (A Nonprofit Corporation)

Investigators